Relative biological effectiveness (RBE), quality factor (Q), and radiation weighting factor (w(R)). A report of the International Commission on Radiological Protection
- PMID: 14614921
- DOI: 10.1016/s0146-6453(03)00024-1
Relative biological effectiveness (RBE), quality factor (Q), and radiation weighting factor (w(R)). A report of the International Commission on Radiological Protection
Abstract
The effect of ionising radiation is influenced by the dose, the dose rate, and the quality of the radiation. Before 1990, dose-equivalent quantities were defined in terms of a quality factor, Q(L), that was applied to the absorbed dose at a point in order to take into account the differences in the effects of different types of radiation. In its 1990 recommendations, the ICRP introduced a modified concept. For radiological protection purposes, the absorbed dose is averaged over an organ or tissue, T, and this absorbed dose average is weighted for the radiation quality in terms of the radiation weighting factor, w(R), for the type and energy of radiation incident on the body. The resulting weighted dose is designated as the organ- or tissue-equivalent dose, H(T). The sum of the organ-equivalent doses weighted by the ICRP organ-weighting factors, w(T), is termed the effective dose, E. Measurements can be performed in terms of the operational quantities, ambient dose equivalent, and personal dose equivalent. These quantities continue to be defined in terms of the absorbed dose at the reference point weighted by Q(L). The values for w(R) and Q(L) in the 1990 recommendations were based on a review of the biological and other information available, but the underlying relative biological effectiveness (RBE) values and the choice of w(R) values were not elaborated in detail. Since 1990, there have been substantial developments in biological and dosimetric knowledge that justify a re-appraisal of w(R) values and how they may be derived. This re-appraisal is the principal objective of the present report. The report discusses in some detail the values of RBE with regard to stochastic effects, which are central to the selection of w(R) and Q(L). Those factors and the dose-equivalent quantities are restricted to the dose range of interest to radiation protection, i.e. to the general magnitude of the dose limits. In special circumstances where one deals with higher doses that can cause deterministic effects, the relevant RBE values are applied to obtain a weighted dose. The question of RBE values for deterministic effects and how they should be used is also treated in the report, but it is an issue that will demand further investigations. This report is one of a set of documents being developed by ICRP Committees in order to advise the ICRP on the formulation of its next Recommendations for Radiological Protection. Thus, while the report suggests some future modifications, the w(R) values given in the 1990 recommendations are still valid at this time. The report provides a scientific background and suggests how the ICRP might proceed with the derivation of w(R) values ahead of its forthcoming recommendations.
Similar articles
-
Effective quality factors for neutrons based on the revised ICRP/ICRU recommendations.Radiat Prot Dosimetry. 2005;115(1-4):536-41. doi: 10.1093/rpd/nci004. Radiat Prot Dosimetry. 2005. PMID: 16381781
-
Weighting factors for radiation quality: how to unite the two current concepts.Radiat Prot Dosimetry. 2004;110(1-4):781-7. doi: 10.1093/rpd/nch164. Radiat Prot Dosimetry. 2004. PMID: 15353747
-
Radiation doses and risks from internal emitters.J Radiol Prot. 2008 Jun;28(2):137-59. doi: 10.1088/0952-4746/28/2/R01. Epub 2008 May 22. J Radiol Prot. 2008. PMID: 18495991 Review.
-
New operational quantities (RBE ×Dp lens/Φ) for eye lens neutron dosimetry as a function of energy and angle of incidence in the ICRU 95 formalism.J Radiol Prot. 2023 Sep 11;43(3). doi: 10.1088/1361-6498/acf383. J Radiol Prot. 2023. PMID: 37619555
-
The impact of ICRP publication 92 on the conversion coefficients in use for cosmic ray dosimetry.Radiat Prot Dosimetry. 2004;109(4):303-9. doi: 10.1093/rpd/nch306. Radiat Prot Dosimetry. 2004. PMID: 15273348 Review.
Cited by
-
Hodgkin's lymphoma emerging radiation treatment techniques: trade-offs between late radio-induced toxicities and secondary malignant neoplasms.Radiat Oncol. 2013 Jan 30;8:22. doi: 10.1186/1748-717X-8-22. Radiat Oncol. 2013. PMID: 23360559 Free PMC article.
-
Influence of Pulse Duration on X-ray Emission during Industrial Ultrafast Laser Processing.Materials (Basel). 2022 Mar 18;15(6):2257. doi: 10.3390/ma15062257. Materials (Basel). 2022. PMID: 35329706 Free PMC article.
-
Estimate of the uncertainties in the relative risk of secondary malignant neoplasms following proton therapy and intensity-modulated photon therapy.Phys Med Biol. 2010 Dec 7;55(23):6987-98. doi: 10.1088/0031-9155/55/23/S02. Epub 2010 Nov 12. Phys Med Biol. 2010. PMID: 21076196 Free PMC article.
-
Dosimetry, Radiobiology and Synthetic Lethality: Radiopharmaceutical Therapy (RPT) With Alpha-Particle-Emitters.Semin Nucl Med. 2020 Mar;50(2):124-132. doi: 10.1053/j.semnuclmed.2019.11.002. Epub 2020 Feb 26. Semin Nucl Med. 2020. PMID: 32172797 Free PMC article. Review.
-
Monte Carlo and analytical model predictions of leakage neutron exposures from passively scattered proton therapy.Med Phys. 2013 Dec;40(12):121714. doi: 10.1118/1.4829512. Med Phys. 2013. PMID: 24320500 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources